Trial NCT01487174

View at ClinicalTrials.gov 
Org. Study IDs: KD019-301

Last trial update was posted on 2022-05-13

MeSH Interventions

Erlotinib Hydrochloride

MeSH Conditions

Carcinoma, Non-Small-Cell Lung

Other Conditions


Stopping Reasons

Kadmon has made a business decision to terminate the study due to slow enrollment. Note the decision to terminate the study was not related to safety issues

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID